Information de reference pour ce titreAccession Number: | 00001716-200706110-00007.
|
Author: | LUDVIGSSON, J. F. *,+; OLSSON, T. ++; EKBOM, A. +,[S]; MONTGOMERY, S. M. +,[P]
|
Institution: | (*)Department of Paediatrics, Orebro University Hospital, Orebro, Sweden +Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden ++Neuroimmunology Unit, Dept. of Clinical Neurosciences, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden [S]Harvard School of Public Health, Boston, MA, USA [P]Clinical Research Centre, Orebro University Hospital, Orebro, Sweden
|
Title: | |
Source: | Alimentary Pharmacology & Therapeutics. 25(11):1317-1327, June 1, 2007.
|
Abstract: | Background: It has been suggested that coeliac disease (CD) is associated with several neurological diseases. However, the evidence of such an association is inconclusive as earlier research has often been based on small numbers with retrospective data collection.
Aim: To use Cox regression to examine the risk of neurological disease in individuals with CD.
Methods: Through Swedish national registers we identified some 14 000 individuals with a diagnosis of CD (1964-2003) and 70 000 reference individuals matched for age, sex, calendar year and county.
Results: Coeliac disease was associated with later polyneuropathy [hazard ratio (HR) = 3.4; 95% CI = 2.3-5.1]. We found no statistically significant association between CD and subsequent multiple sclerosis (HR = 0.9; 95% CI = 0.3-2.3), Parkinson's disease (HR = 1.2; 95% CI = 0.8-1.9), Alzheimer's disease (HR = 1.5; 95% CI = 0.9-2.6), hereditary ataxia (HR = 1.3; 95% CI = 0.5-3.6), the symptom ataxia (HR = 1.9; 95% CI = 0.6-6.2), Huntington's disease (HR = 1.7; 95% CI = 0.3-8.6), myasthenia gravis (HR = 0.8; 95% CI = 0.2-3.8) or spinal muscular atrophy (HR = 0.5; 95% CI = 0.1-3.8). Prior polyneuropathy was associated with subsequent CD (odds ratio = 5.4; 95% CI = 3.6-8.2).
Conclusions: The association between CD and polyneuropathy indicates shared risks. We suggest that individuals with polyneuropathy routinely undergo screening for CD. There is no notable association between CD and other neurological outcomes investigated in this study.
Copyright (C) 2007 Blackwell Publishing Ltd.
|
References: | 1 Dube C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005; 4: S57-67.
2 Bushara KO. Neurologic presentation of celiac disease. Gastroenterology 2005; 4: S92-7.
3 Bushara KO, Goebel SU, Shill H, Goldfarb LG, Hallett M. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 2001; 49: 540-3.
4 Hadjivassiliou M, Grunewald R, Sharrack B, et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain 2003; 126: 685-91.
5 Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000; 48: 211-9.
6 Lincoln MR, Montpetit A, Cader MZ, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005; 37: 1108-12.
7 Sawcer S, Ban M, Maranian M, et al. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005; 77: 454-67.
8 Monsuur AJ, Bakker PI, Alizadeh BZ, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005; 37: 1341-4.
9 Kemppainen T, Kroger H, Janatuinen E, et al. Osteoporosis in adult patients with celiac disease. Bone 1999; 24: 249-55.
10 Kupper C. Dietary guidelines and implementation for celiac disease. Gastroenterology 2005; 4: S121-7.
11 Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60-5.
12 Salvatore S, Finazzi S, Ghezzi A, et al. Multiple sclerosis and celiac disease: is there an increased risk? Mult Scler 2004; 10: 711-2.
13 Pengiran Tengah CD, Lock RJ, Unsworth DJ, Wills AJ. Multiple sclerosis and occult gluten sensitivity. Neurology 2004; 62: 2326-7.
14 Pellecchia MT, Ambrosio G, Salvatore E, Vitale C, De Michele G, Barone P. Possible gluten sensitivity in multiple system atrophy. Neurology 2002; 59: 1114-5.
15 Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286-92.
16 Frisoni GB, Carabellese N, Longhi M, et al. Is celiac disease associated with Alzheimer's disease? Acta Neurol Scand 1997; 95: 147-51.
17 Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? [see comments]. Lancet 1996; 347: 369-71.
18 Pellecchia MT, Scala R, Filla A, De Michele G, Ciacci C, Barone P. Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry 1999; 66: 32-5.
19 Kieslich M, Errazuriz G, Posselt HG, Moeller-Hartmann W, Zanella F, Boehles H. Brain white-matter lesions in celiac disease: a prospective study of 75 diet-treated patients. Pediatrics 2001; 108: E21.
20 Volta U, De Giorgio R, Petrolini N, et al. Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders. Scand J Gastroenterol 2002; 37: 1276-81.
21 Hu WT, Murray JA, Greenaway MC, Parisi JE, Josephs KA. Cognitive impairment and celiac disease. Arch Neurol 2006; 63: 1440-6.
22 Hadjivassiliou M, Grunewald RA, Kandler RH, et al. Neuropathy associated with gluten sensitivity. J Neurol Neurosurg Psychiatry 2006; 77: 1262-6.
23 Luostarinen L, Himanen SL, Luostarinen M, Collin P, Pirttila T. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J Neurol Neurosurg Psychiatry 2003; 74: 490-4.
24 Pengiran Tengah DS, Wills AJ, Holmes GK. Neurological complications of coeliac disease. Postgrad Med J 2002; 78: 393-8.
25 Cicarelli G, Della Rocca G, Amboni M, et al. Clinical and neurological abnormalities in adult celiac disease. Neurol Sci 2003; 24: 311-7.
26 Holmes GK. Neurological and psychiatric complications in coeliac disease. Epilepsy and other Neurological Disorders in Coeliac Disease (NB. This reference was cited through Rosenberg et al. J Neurol Neurosurg Psychiatry. 2005: 76: 1415-19). London: John Libby, 1997.
27 Luostarinen L, Pirttila T, Collin P. Coeliac disease presenting with neurological disorders. Eur Neurol 1999; 42: 132-5.
28 Chin RL, Sander HW, Brannagan TH, et al. Celiac neuropathy. Neurology 2003; 60: 1581-5.
29 Rosenberg NR, Vermeulen M. Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy? J Neurol Neurosurg Psychiatry 2005; 76: 1415-9.
30 Chin RL, Tseng VG, Green PH, Sander HW, Brannagan TH 3rd, Latov N. Multifocal axonal polyneuropathy in celiac disease. Neurology 2006; 66: 1923-5.
31 Briani C, Zara G, Toffanin E, et al. Neurological complications of celiac disease and autoimmune mechanisms: preliminary data of a prospective study in adult patients. Ann N Y Acad Sci 2005; 1051: 148-55.
32 Brannagan TH 3rd, Hays AP, Chin SS, et al. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch Neurol 2005; 62: 1574-8.
33 Bushara KO, Nance M, Gomez CM. Antigliadin antibodies in Huntington's disease. Neurology 2004; 62: 132-3.
34 Barta Z, Mekkel G, Zeher M. Antigliadin antibodies in Huntington's disease. Neurology 2004; 63: 762; author reply 762.
35 Edwards JH. Letter: gluten and myasthenia gravis. Lancet 1975; 2: 41.
36 Gundlach HJ, Ernst K. Regressive myopathy with myasthenic syndrome in idiopathic gluten enteropathy. Psychiatr Neurol Med Psychol (Leipz) 1975; 27: 225-30.
37 Hadjivassiliou M, Chattopadhyay AK, Davies-Jones GA, Gibson A, Grunewald RA, Lobo AJ. Neuromuscular disorder as a presenting feature of coeliac disease. J Neurol Neurosurg Psychiatry 1997; 63: 770-5.
38 Stenhammar L, Hogberg L, Danielsson L, et al. How do Swedish paediatric clinics diagnose coeliac disease? Results of a nationwide questionnaire study. Acta Paediatr 2006; 95: 1495-7.
39 Johannesson I. The Total Population Register of Statistics Sweden. Possibilities and Better Quality. Orebro: Statistiska Centralbyran, 2005.
40 Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35: 1215-8.
41 Kelly JJ, Karcher DS. Lymphoma and peripheral neuropathy: a clinical review. Muscle Nerve 2005; 31: 301-13.
42 Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002; 123: 1428-35.
43 Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes 2003; 52: 2867-73.
44 Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004; 27: 1458-86.
45 Bao F, Yu L, Babu S, et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun 1999; 13: 143-8.
46 Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. Jama 2003; 290: 1721-8.
47 Norris JM, Barriga K, Hoffenberg EJ, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. Jama 2005; 293: 2343-51.
48 Odetti P, Valentini S, Aragno I, et al. Oxidative stress in subjects affected by celiac disease. Free Radic Res 1998; 29: 17-24.
49 Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005; 59: 365-73.
50 Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how 'high-grade' systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003; 108: 2957-63.
51 Lee SK, Lo W, Memeo L, Rotterdam H, Green PH. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc 2003; 57: 187-91.
52 Hadjivassiliou M, Boscolo S, Davies-Jones GA, et al. The humoral response in the pathogenesis of gluten ataxia. Neurology 2002; 58: 1221-6.
53 Kagnoff MF. Overview and pathogenesis of celiac disease. Gastroenterology 2005; 4: S10-8.
54 Mold JW, Vesely SK, Keyl BA, Schenk JB, Roberts M. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract 2004; 17: 309-18.
55 Scalabrino G, Buccellato FR, Veber D, Mutti E. New basis of the neurotrophic action of vitamin B12. Clin Chem Lab Med 2003; 41: 1435-7.
56 Puri V, Chaudhry N, Goel S, Gulati P, Nehru R, Chowdhury D. Vitamin B12 deficiency: a clinical and electrophysiological profile. Electromyogr Clin Neurophysiol 2005; 45: 273-84.
57 Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 1986; 21: 193-200.
58 Fredrikson S, Cheng Q, Jiang GX, Wasserman D. Elevated suicide risk among patients with multiple sclerosis in Sweden. Neuroepidemiology 2003; 22: 146-52.
59 Landgren O, Engels EA, Caporaso NE, et al. Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood 2006; 108: 292-6.
60 Fored CM, Fryzek JP, Brandt L, et al. Parkinson's disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders. Occup Environ Med 2006; 63: 135-40.
61 Rosengren A, Skoog I, Gustafson D, Wilhelmsen L. Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med 2005; 165: 321-6.
62 Miao J, Brismar K, Nyren O, Ugarph-Morawski A, Ye W. Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care 2005; 28: 2850-5.
63 Nilsson AC, Spetz CL, Carsjo K, Nightingale R, Smedby B. Reliability of the hospital registry. The diagnostic data are better than their reputation. Lakartidningen 1994; 91: 598.
64 Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005; 54: 54-9.
65 Danielsson L, Stenhammar L, Ascher H, et al. Proposed criteria for diagnosis of celiac disease in children. Lakartidningen 1998; 95: 2342-3.
|
Language: | English.
|
Document Type: | ORIGINAL ARTICLE.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0269-2813
|
NLM Journal Code: | a5d, 8707234
|
Annotation(s) | |
|
|